Department of Pharmacy, University of Parma, Viale Usberti 27/A, 43100 Parma, Italy.
Eur J Pharm Sci. 2011 Apr 18;42(5):503-8. doi: 10.1016/j.ejps.2011.02.008. Epub 2011 Feb 23.
The aim of the work was to study in vitro, across isolated porcine sclera and across the trilayer sclera-choroid-Bruch's membrane (SCB), the effect of iontophoresis on the permeation of a 40 kDa dextran (FD-40), chosen as model compound of high molecular weight neutral drugs. In particular, the effect of vehicle composition (in terms of buffering agent and ionic strength) and current intensity (from 0.3 to 4.2 mA, corresponding to 0.5-7 mA cm(-2)) was investigated. Additionally the post-iontophoretic transport of FD-40 through SCB was studied. The results obtained in the present paper confirm the importance of formulation parameters during transscleral iontophoresis of a neutral high molecular weight hydrophilic compound transported by electroosmosis. In particular, ionic strength seems to be the more relevant parameter, while the buffering agent (phosphate vs HEPES) is not relevant. The enhancement obtained increases--although in a stepwise way--with current intensity, after a threshold value of approximately 1.5 mA. However, the real variable to be considered is probably current density (threshold value 2.5 mA cm(-2)) more than intensity, in analogy with transdermal iontophoresis. The inclusion of further static barriers besides the sclera, such as choroid and Bruch's membrane, reduces, as expected, the permeation of FD-40, but iontophoresis is able to significantly promote FD-40 transport also through this more complex barrier, without altering its permeability. Finally, the study of the post-iontophoretic transport highlights the formation of a pronounced FD-40 reservoir inside the sclera. This reservoir permits to obtain in vitro a sustained transscleral flux up to 3 h after current stop. This result could be of interest in the case of a real application, prolonging the enhancement effect also after iontophoresis stop.
本研究旨在通过离体猪巩膜和巩膜-脉络膜-视网膜色素上皮(SCB)三层复合体模型,研究电渗析对高相对分子质量中性药物模型化合物 40kDa 葡聚糖(FD-40)渗透的体外影响。具体而言,考察了载体组成(缓冲剂和离子强度)和电流强度(0.3-4.2mA,相当于 0.5-7mA/cm²)对渗透的影响。此外,还研究了 FD-40 经 SCB 电渗析后的后续转运。本研究结果证实了在高相对分子质量亲水性中性化合物经电渗析跨巩膜转运过程中,制剂参数的重要性。特别是,离子强度似乎是更相关的参数,而缓冲剂(磷酸盐与 HEPES)则不相关。增强作用虽然呈阶梯式增加,但在约 1.5mA 后达到一个阈值。然而,真正需要考虑的变量可能是电流密度(阈值 2.5mA/cm²),而不是强度,这与经皮电渗类似。除了巩膜外,还包括脉络膜和视网膜色素上皮等其他静态屏障,这降低了 FD-40 的渗透,这是意料之中的,但电渗析仍能显著促进 FD-40 经此更为复杂的屏障的转运,而不改变其通透性。最后,对电渗析后转运的研究突出了 FD-40 在巩膜内形成一个明显的储库。该储库可使在电流停止后 3h 内体外持续跨巩膜通量。这一结果在实际应用中可能具有重要意义,可延长电渗析停止后的增强效果。